FDA Panel Rejects Weight-Loss Pill
July 15, 2010, 3:12 PM
GAITHERSBURG, MD -
A Food and Drug Administration panel has voted 9-7 against Vivus Inc.'s Qnexa citing the experimental obesity treatment's negative side effects.
Federal health advisers say the negative effects on concentration and memory outweigh its ability to help patients lose
The vote deals a major setback to the Mountainview, CA drugmaker which is racing two other small California drugmakers to
market its weight-loss pill.
The FDA will consider the panel's recommendation and make a final decision later this year.
The agency has not approved a new prescription weight loss pill in over a decade, and currently available drugs have limited effectiveness and worrisome side effects.
© 2010 Associated Press. All rights reserved. Material may not be redistributed.
8/25/2014 2:34 PM
The CEO of Sutton Bay Resort in central South Dakota died after rolling his 2014 Polaris Ranger late Sunday night.
8/24/2014 10:43 AM
31-year-old Bridget Franzen failed to report to a work release job on Saturday, August 23.
8/27/2014 5:48 PM
Her boyfriend was killed during a botched robbery in December in northwest Sioux Falls. Faith Rasmussen and her mother, Theresa, have now pleaded guil...
8/27/2014 10:54 AM
Faith Rasmussen, 21, and her 55-year-old mother Theresa Rasmussen admit they were bringing marijuana from California to South Dakota and distributing ...
8/26/2014 11:31 AM
Authorities in northwest Iowa are investigating a serious crash involving a car and a school bus.